IMR Press / FBL / Volume 3 / Issue 6 / DOI: 10.2741/A386

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article

Therapy cost 2000: an electronic tool for evaluating the cost-effectiveness of therapeutic regimens

Show Less
1 Pfizer Inc, New York, NY, USA
Front. Biosci. (Landmark Ed) 1998, 3(6), 3–4; https://doi.org/10.2741/A386
Submitted: 24 November 1998 | Accepted: 26 November 1998 | Published: 1 December 1998
Abstract

Providing quality care to patients at the lowest cost is of primary concern to hospitals, clinics, managed care organizations, integrated health systems, and other health care providers operating in a prospective payment environment. Therapy Cost 2000 can help health care providers and decision-makers in a variety of settings reach the goal of cost-effective, high-quality patient care.

Keywords
Health
Therapy
Patient
Software
Cost
Share
Back to top